VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Benjamin Terrier, Bénédicte Oulès et al.|Nature Communications|2024Cited by 87
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomyFrançois Vercruysse, Marie‐Elise Truchetet, Thomas Barnetche et al.|Arthritis Research & Therapy|2019Cited by 75
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin De Valence, Mikaël Ebbo, M. Delaune et al.|Annals of the Rheumatic Diseases|2023Cited by 70
Un doigt bleuF. Blaison, Valentine Baudry, François Lifermann|La Revue de Médecine Interne|2018Cited by 0